Skip to main content

Find Clinical Trials

Home
Conditions
Glomerulonephritis, Membranous

Clinical trial condition

Glomerulonephritis, Membranous

Explore clinical trials studying Glomerulonephritis, Membranous. Study availability and eligibility vary by location and protocol.

71 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis, Membranous trial results

Completed

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

NCT04733040

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Managadze National Center of Urology Tbilisi, Georgia

Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic Tbilisi, Georgia

University Hospital Aachen Aachen, Germany

Charite Berlin, Germany

View all 25 locations

View Trial Details

Completed

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

NCT04278729

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

NCT01845688

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Adrenocorticotropic Hormone in Membranous Nephropathy

NCT03025828

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

NCT01508468

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Department of Nephrology , Tenon hospital - APHP Paris, France

View Trial Details

Completed

Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy

NCT03255447

Conditions: Autoimmune Diseases, Autoimmune Membranous Nephropathy, Female Urogenital Diseases, +9 more
Locations: Central Manchester University Hospital Foundation Trust Manchester, Greater Manchester, United Kingdom

Royal Preston Hospital Preston, Lancashire, United Kingdom

Salford Royal Infirmary Salford, Lancashire, United Kingdom

View Trial Details

Completed

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

NCT01955187

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Hospital 12 de Octubre Madrid, Spain

View Trial Details

Completed

Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

NCT00843856

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Hammersmith Hospital London, United Kingdom

View Trial Details

Completed

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

NCT01386554

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Mallinckrodt Investigational Site Sacramento, California, United States

Mallinckrodt Investigational Site Stanford, California, United States

Mallinckrodt Investigational Site Jacksonville, Florida, United States

Mallinckrodt Investigational Site Atlanta, Georgia, United States

View all 28 locations

View Trial Details

Completed

Rituximab in Refractory Primary Membranous Nephropathy

NCT03880643

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Istanbul University Istanbul, Turkey (Türkiye)

View Trial Details